Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J McCune

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Clinical and Experimental Rheumatology|August 4, 2009
Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosisJ D Finkielman, P A Merkel, D Schroeder, et al.
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
Serologic features of cohorts with variable genetic risk for systemic lupus erythematosusJyotsna Bhattacharya, Karalyn Pappas, Bahtiyar Toz, et al.
Clinical and Experimental Immunology|January 12, 2017
Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitisJ M Clain, A M Hummel, J H Stone, et al.
The Journal of Clinical Investigation|October 28, 2021
The intersection of COVID-19 and autoimmunityJason S Knight, Roberto Caricchio, Jean-Laurent Casanova, et al.
Medrxiv : the Preprint Server for Health Sciences|March 11, 2026
Clinical, <i>in vitro,</i> and <i>in vivo</i> evidence of <i>WAPL</i> as a novel cohesinopathy gene and phenotypic driver of 10q22.3q23.2 genomic disorderPhilip M Boone, Serkan Erdin, Abucar Mohamed, et al.
American Journal of Human Genetics|July 10, 2026
Clinical, in vitro, and in vivo evidence of WAPL as a cohesinopathy-associated gene and phenotypic driver of 10q22.3q23.2 genomic disorderPhilip M Boone, Serkan Erdin, Abucar Mohamed, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Clinical and Experimental Rheumatology|August 4, 2009
Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosisJ D Finkielman, P A Merkel, D Schroeder, et al.
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
Serologic features of cohorts with variable genetic risk for systemic lupus erythematosusJyotsna Bhattacharya, Karalyn Pappas, Bahtiyar Toz, et al.
Clinical and Experimental Immunology|January 12, 2017
Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitisJ M Clain, A M Hummel, J H Stone, et al.
The Journal of Clinical Investigation|October 28, 2021
The intersection of COVID-19 and autoimmunityJason S Knight, Roberto Caricchio, Jean-Laurent Casanova, et al.
Medrxiv : the Preprint Server for Health Sciences|March 11, 2026
Clinical, <i>in vitro,</i> and <i>in vivo</i> evidence of <i>WAPL</i> as a novel cohesinopathy gene and phenotypic driver of 10q22.3q23.2 genomic disorderPhilip M Boone, Serkan Erdin, Abucar Mohamed, et al.
American Journal of Human Genetics|July 10, 2026
Clinical, in vitro, and in vivo evidence of WAPL as a cohesinopathy-associated gene and phenotypic driver of 10q22.3q23.2 genomic disorderPhilip M Boone, Serkan Erdin, Abucar Mohamed, et al.
Pageof 11